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Abstract
Objective—Lipid-soluble antioxidants are associated with a lower incidence for many chronic
diseases of aging, possibly by preventing damage from chronic inflammation. In the current study,
we compared serum levels of coenzyme Q10 (CoQ10), α-tocopherol, γ-tocopherol, and C-reactive
protein (CRP) between adolescent girls and premenopausal women to assess changes from
childhood to midlife.
Methods—Baseline serum CoQ10, α-tocopherol, γ-tocopherol, and CRP levels were measured in
207 girls (13-19 years) and 183 premenopausal women (34-47 years) using standard methods and
the two age groups were compared by t-test. The influence of age, body mass index (BMI) and
race/ethnicity and interaction effects on serum values were assessed using analysis of covariance.
Pearson correlation coefficients were used to assess associations between pairs of lipid
micronutrients.
Results—Overall, adolescent girls had significantly lower mean serum CoQ10, α-tocopherol, γ-
tocopherol, and CRP levels relative to premenopausal women (CoQ10: 376 vs. 544 ng/mL,
P<0.0001; α-tocopherol: 6.9 vs. 13.5 μg/mL, P<0.0001; γ-tocopherol: 1.3 vs. 1.7 μg/mL,
P<0.0001; CRP: 1.29 vs. 2.13 mg/L, P<0.0001). The differences in CoQ10 and tocopherols
remained significant after adjustment for BMI and race/ethnicity. CoQ10 was significantly and
positively correlated to α- and γ-tocopherol, and BMI was positively associated with CRP and γ-
tocopherol in both groups.
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Conclusions—Lower serum CoQ10, α-tocopherol, γ-tocopherol, and CRP levels in adolescent
girls compared to women suggests that adolescents may have a reduced need for antioxidants
possibly due to their lower BMI and inflammatory status as indicated by CRP.
Keywords
Adolescent girls; premenopausal women; coenzyme Q10; tocopherols; C-reactive protein; Body
mass index
Introduction
Tocopherols and Coenzyme Q10 (CoQ10) are postulated to protect against the development
of cancer and other aging-related diseases due to their important roles in preventing cellular
oxidative damage as a result of chronic inflammation [1-4]. In addition, CoQ10 is a rate-
limiting component of the mitochondrial electron transport system leading to ATP
production which is essential for eukaryotic cell survival and energy requiring processes,
including proliferation, apoptosis, angiogenesis, and immune function [5-8].
Epidemiological evidence, while limited, suggests inverse associations of tocopherols and
CoQ10 with the risk of certain cancers [9-11]. While α-tocopherol appears to be a primary
reactant against cellular oxidants [12], γ-tocopherol has been suggested as a key cellular
antioxidant that limits cellular damage from the enzymatic production of nitric oxide (NO),
a mediator of inflammation through its oxidation products [13-15]. Together, both α- and γ-
tocopherols protect cells from the major forms of endogenous oxidative attack. The Institute
of Medicine has identified 6 μg/ml of α-tocopherol in the blood as adequate for vitamin E
nutrition and concludes there is currently insufficient evidence to declare a requirement for
γ-tocopherol [16], however, much controversy exists as to the levels and types of
tocopherols necessary for optimal nutrition and prevention of chronic diseases of aging.
Circulating CoQ10 levels were reported to be highly, positively correlated to circulating
tocopherol levels [11, 17], suggesting either a causal relationship or a common regulatory
mechanism. Since γ-tocopherol levels rise in response to inflammation [12, 13], the strong
association between blood CoQ10 and tocopherol levels suggests that elevated CoQ10 levels
in the circulation may be mediated by systemic and/or localized inflammation. Thus, lower
circulating CoQ10 levels may suggest inadequate cellular levels, low inflammation,
enhanced excretion, and/or reduced immune function. In addition as all cells are capable of
synthesizing CoQ10 [18, 19] and CoQ10 functions in the mitochondria, the physiological
meaning of elevated blood CoQ10 levels with age is not clearly understood.
With the exception of infancy, pregnancy and lactation periods, energy and nutrient needs
are greater during adolescence compared to any other time of life due to the rapid changes in
the physical development of adolescents [20]. On the other hand, the dramatic physiological
changes in this period may also affect the regulatory process determining levels of serum
lipid-soluble antioxidants. Given the hypothesized importance of lipid-soluble antioxidants
for chronic disease prevention and the lack of data related to tocopherols and CoQ10 in
adolescents, we examined the distribution of serum levels of CoQ10, tocopherols (α-
tocopherol and γ-tocopherol), and C-reactive protein (CRP) in two female populations,
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adolescent girls and premenopausal women to determine what may be considered normal
values during the early aging process and what levels may be indicative of pathology.
Materials and Methods
Subjects and study design
The current study used stored serum samples and data from the Female Adolescent
Maturation (FAM) cohort study [21, 22] and a soy intervention study conducted in
premenopausal women (BEAN study) [23]. The Institutional Review Boards of the
University of Hawaii, Kaiser Permanente of Hawaii, and the University of Hawaii Clinical
Research Center at Kapiolani Medical Center approved both studies. Data from 390
participants including 207 adolescent girls and 183 premenopausal women were analyzed in
the current study.
Briefly, there were three studies (FAM1, FAM 2, and FAM3) involved in the FAM cohort
[21, 22]. FAM1 consisted of healthy female adolescents from 9 to 14 years of age recruited
from membership files of Kaiser Permanente Hawaii (Oahu) in 2000-2001. Inclusion criteria
consisted of no history of chronic disease, non-smoking, not using or having used oral
corticosteroids, oral contraceptives or other steroid hormones, and no pre-existing medical
conditions such as thyroid, chronic asthma, and epilepsy requiring medication. FAM1
participants returned for two more exams in 2002-2003 (FAM2) and 2004-2005 (FAM3),
respectively. In 2005-2007, new participants aged from 12 to 18 years were additionally
recruited with the similar inclusion criteria as those mentioned above (FAM3). FAM3 only
included 30 of the original girls and majority of the participants were new recruits. The
current analysis utilized a cross-sectional design and FAM3 data, since the blood samples
were only obtained in FAM3; 207 participants had data for tocopherols, CoQ10, and CRP.
In the BEAN study conducted in 2000-2003 [23], 220 women aged 35 to 46 years were
randomly assigned to either the soy intervention or the control group. Inclusion criteria
ensured that all subjects had a normal screening mammogram, were not taking oral
contraceptive pills or other sex hormones, had no history of cancer, had a complete uterus
and ovaries, menstruated regularly, and consumed less isoflavones than the equivalent of 6
servings of soy/week during the previous year. The baseline data of the BEAN study were
used in the current study as the effect of soy intervention was not of interest; biomarkers
were available for 182 participants (182 for CRP and 172 for CoQ10 and tocopherols).
Sample analysis
All serum samples were stored at -80°C immediately after blood collection and were never
previously thawed before extraction to minimize the outcome variations due to storage
conditions such as temperature and storage duration from collection to processing. The
storage durations between sample collection and analysis for FAM3 and BEAN studies were
approximately 1 to 3 years and 5 to 8 years, respectively. The samples were extracted using
hexane after the addition of δ-tocopheryl laurate as an internal standard. The extracts were
then stored at −80°C for subsequent total CoQ10 analysis by high-performance liquid
chromatography (HPLC, ThermoFisher) with pre-column electrochemical oxidation and
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post-column UV detection. Separation of analytes was done on a Gemini C18 analytic
column (Phenomenex) as described previously [24]. Duplicate samples from QC plasma
pools were included in each analysis batch and the range of interassay variability was 5% to
7%. Serum concentrations of tocopherols were analyzed using HPLC as previously
described [25]. Assays were regularly validated for tocopherols through inclusion of
external standards in each analysis batch and by participation in quality assurance programs
organized by the US National Institute of Standards and Technology (NIST, Gaithersburg,
MD) every year since 1999 [26].
CRP was measured with an automated chemical analyzer (Cobas MiraPlus, Roche
Diagnostics, Switzerland). Kits based on latex immuno reactions followed by turbidimetric
measurements were used from Pointe Scientific, Inc. (Canton, MI). The intra-batch
coefficients of variations (CV) for CRP ranged from 5% to 7%.
Statistical analysis
The differences in means for measured biomarkers (α-tocopherol, γ-tocopherol, CoQ10, and
CRP) between adolescent girls and premenopausal women were compared using the
student’s t test. Analysis of covariance was applied to estimate mean levels for the two
female groups adjusted for body mass index (BMI), race/ethnicity, and tobacco smoking
status (current smoker vs. current non-smoker). The analyses were also repeated in Asians
and Whites since these two race/ethnic group had relatively large sample size. Relationships
between tocopherols and CoQ10 and associations of these biomarkers with BMI were
assessed by Pearson correlation coefficients. CRP was log-transformed to normalize its
distribution. Weight categories (underweight, <5th percentile; healthy weight, 5th – 84th;
overweight, 85th – 94th; and obese, ≥ 95th) in girls were determined using BMI for age
percentiles developed by the National Center for Health Statistics in collaboration with the
National Center for Chronic Disease Prevention and Health Promotion (2000) [27]. SAS 9.2
software (SAS Institute, Cary, NC) was used for all statistical analyses, and all P values <
0.05 were considered statistically significant.
Results
Mean ages were 15.6 ± 1.5 and 43.0 ± 2.9 years for adolescent girls and premenopausal
women, respectively. Women in our study were more likely to be overweight (26.2% vs.
11.4%) or obese (22.4% vs. 7.9%) compared with the girls (Table 1). In girls, 41.7% were
Asians, 18.2% were whites, and 29.7% were native Hawaiians/ Pacific Islanders. The
respective proportions in women were 40.4%, 36.6%, and 12.6%. Six percent of the women
were current smokers while all of the girls that participated in the study were non-smokers.
Table 2 shows serum levels of tocopherols, CoQ10, and CRP for the two female groups.
Adolescent girls had statistically significantly lower serum α-tocopherol, γ-tocopherol,
CoQ10, and CRP levels compared to premenopausal women. The differences in tocopherols
and CoQ10 remained significant after adjustment for BMI and after additional adjustment for
race/ethnicity or smoking status. However, the difference in CRP was no longer significant
after adjusting for BMI. There were no statistically significant interactions of age group with
BMI and race/ethnicity in relation to the biomarkers (α-tocopherol, γ-tocopherol, CoQ10,
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and CRP) (Ps > 0.05). Statistically significant differences in serum concentrations of α-
tocopherol, γ-tocopherol, and CoQ10 levels between the age groups (adolescent girls vs.
premenopausal women) were also observed in both Asian (Ps < 0.05) and White (Ps < 0.05)
race/ethnic groups. Serum CRP levels were significantly lower in the girls than women
among Whites (P = 0.005) while no significant group differences were observed among
Asians (P = 0.68). As expected, the difference in serum CRP levels between adolescent girls
and premenopausal women in Whites was not significant after adjusting for BMI (P = 0.94).
A comparison of the distributions of α- and γ-tocopherol, and CoQ10 values (Figures 1)
showed that girls had a much smaller variance for all three lipid micronutrients, but in
particular for α-tocopherol and total CoQ10 relative to premenopausal women.
In both girls and women, BMI was significantly, positively associated with serum CRP
(girls: r = 0.32, P < 0.0001; women: r = 0.56, P < 0.0001) and γ-tocopherol (girls: r = 0.17, P
= 0.02; women: r = 0.25, P = 0.0008) levels. Significant, positive associations of CoQ10 with
serum α-tocopherol (girls, r = 0.33, P < 0.0001; women, r = 0.21, P = 0.0007) and with γ-
tocopherol (girls, r = 0.27, P = 0.0001; women, r = 0.38, P < 0.0001) levels were observed in
both groups.
Discussion
In the current study, we observed significantly lower CRP levels, a biomarker for
inflammation in adolescent girls than premenopausal women. Chronic systemic
inflammation is observed among overweight and obese individuals, BMI > 25 kg/m2 [28]
and may contribute to the long-term health consequences associated with obesity. The
higher proportion of overweight (26.2% vs. 11.4%) and obese individuals (22.9% vs. 7.9%)
in premenopausal women than girls are in agreement with the CRP findings. The fact that
the difference in CRP between the groups was no longer significant after adjustment for
BMI confirms the association between BMI and CRP. Consistent with this observation, Ford
et al. [29] examined CRP levels among 14,519 U.S. non-institutionalized men and women
aged ≥ 20 years using National Health and Nutrition Examination Survey III (1988–1994)
data and reported that participants with elevated circulating CRP levels were older and
heavier compared to those with lower CRP levels.
The current results indicated that adolescent girls also had significantly lower serum α-
tocopherol, γ-tocopherol, and CoQ10 levels compared to premenopausal women; these
differences were independent of BMI status. Chronic inflammation may result in chronic
oxidative stress, a state of imbalance between the production of reactive oxygen species and
antioxidant defenses [28] which is associated with the pathogenesis of many chronic
diseases such as type 2 diabetes, cardiovascular diseases, and cancer [30-32]. The state of
chronic inflammation may be an important determinant of serum levels of lipid-soluble
antioxidants. The lower CRP levels in the girls suggest that the girls may have a reduced
need for circulating lipid-soluble antioxidants to protect cells against damage associated
with inflammation caused by reactive oxygen species. Consistent with this hypothesis, we
observed lower serum levels of α-tocopherol, γ-tocopherol, and CoQ10 in girls than adult
females.
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CoQ10 was significantly, positively associated with both serum α- and γ-tocopherol levels in
both female groups. The positive associations between CoQ10 and circulating tocopherols
(both α-tocopherol and γ-tocopherol) agree with our previous observations [11, 17]. The
mechanism by which circulating tocopherol levels are regulated is presently unknown;
however, the role of tocopherols in chronic inflammation is of great potential significance.
In particular, research using animals and cultured fibroblasts suggests that γ-tocopherol and
its metabolites possess anti-inflammatory activity [12, 33], and γ-tocopherol levels were
observed to rise in response to inflammation [13]. Therefore, the close relationship between
CoQ10 and tocopherols suggests that the rise in circulating CoQ10 levels, like γ-tocopherol,
may also be mediated by inflammation, either systemic and/or localized. Increased blood
CoQ10 levels may be a response to processes such as inflammation, apoptosis, and cellular
necrosis, while reduced circulating CoQ10 levels may represent inadequate cellular levels,
low inflammation, enhanced excretion, and/or inadequate immune function. In the current
study, the lower levels of serum CoQ10 and α- and γ-tocopherols observed in the girls
compared with women may be due to lower BMI and inflammatory status as reflected by
serum CRP levels.
This is the first study to compare serum levels of tocopherols, CoQ10 and CRP between the
two female populations, namely adolescent girls and premenopausal women. One limitation
of the study is that the study populations (adolescent girls and premenopausal women)
originated from two separate, independent investigations, though both were in Hawaii. The
outcomes should not be seriously affected however, as the two original studies (FAM3 and
BEAN study) had similar race/ethnicity distributions, comparable inclusion and exclusion
criteria, regarding health related variables, and all analyses were performed in the same
laboratory. Our study was also limited because of its cross-sectional design, preventing the
unequivocal determination of the temporal relationship for the observed associations
between CoQ10 and tocopherols in both female groups and thus from assessing causality.
Conclusion
Our results suggest that adolescent girls have lower serum CoQ10, α-tocopherol, γ-
tocopherol, and CRP levels compared to premenopausal women. The distributions in girls
also had a smaller variance relative to women. We hypothesize that teenage girls may have a
reduced need for circulating antioxidants, as a consequence of their lower inflammatory
status indicated by the lower BMI and serum CRP levels.
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Figure 1.
Comparison of distribution of Coenzyme Q10 (CoQ10) (A), α-tocopherol (αT) (B), and γ-
tocopherol (γT) (C) values between adolescent girls (n=207) and premenopausal women (n
= 172). The number of participants in each group with CoQ10 or αT values was determined
for each 0.2 μg/mL increase in serum CoQ10 or αT concentrations and plotted as a
percentage of the total number of participants analyzed in each group. The number of
participants in each female group with γT values was determined for each 0.4 μg/mL
increase in serum γT concentrations and plotted as a percentage of the total number of
participants analyzed in each group.
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Table 1
Age, race/ethnicity, and weight status of adolescent girls and premenopausal women1
Adolescent girls (n = 207) Premenopausal women (n=183)
Age (years)2 15.6 ± 1.5 43.0 ± 2.9
Body mass index (BMI, Kg/m2) 22.1 ± 4.2 26.1 ± 5.7
Weight status, n (%)3,4
 Underweight 6 (3.0%) 3 (1.6%)
 Normal/healthy weight 157 (77.7%) 91 (49.7%)
 Overweight 23 (11.4%) 48 (26.2%)
 Obese 16 (7.9 %) 41 (22.4%)
Race/ethnicity, n (%)5
 Asian 80 (41.7%) 74 (40.4%)
 White 35 (18.2%) 67 (36.6%)
 Native Hawaiian /Pacific Islander 57 (29.7%) 23 (12.6%)
 Other 20 (10.4%) 19 (10.4%)
1
Data are given as means ± SD, unless otherwise specified
25 participants had missing values.
3Weight status for adolescent girls was defined using body mass index-for-age percentiles (underweight, <5th percentile; healthy weight, 5th –
84th; overweight, 85th – 94th; Obese, ≥ 95th). For premenopausal women, weight status was defined by BMI values (underweight, < 18.5 kg/m2;
normal weight, 18.5 – 24.9 kg/m2; overweight, 25-29.9 kg/m2; obese, ≥ 30 kg/m2).
45 participants had missing values.
515 participants had missing values.
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Table 2
Serum Levels of Coenzyme Q10 (CoQ10), α-Tocopherol, γ-Tocopherol, and C-reactive protein (CRP) for
adolescent girls and premenopausal women1
Serum biomarker Adolescent girls (n =207) Premenopausal women (n = 183) P2
CoQ10 (ng/mL) 3 376 (361 – 390) 544 (511 – 578) < 0.0001
α-Tocopherol (μg/mL) 3 6.9 (6.7 – 7.1) 13.5 (12.7 – 14.4) < 0.0001
γ-Tocopherol (μg/mL) 3 1.3 (1.2 – 1.4) 1.7 (1.5 – 1.8) < 0.0001
CRP (mg/L) 1.29 (0.89 – 1.69) 2.13 (1.67 – 2.60) < 0.0001
Body mass index and race/ethnicity adjusted value
CoQ10 (ng/mL)3 379 (354 – 403) 535 (509 – 561) < 0.0001
α-Tocopherol (μg/mL)3 6.8 (6.2 – 7.4) 13.6 (13.0 – 14.3) < 0.0001
γ-Tocopherol (μg/mL)3 1.3 (1.2 – 1.4) 1.6 (1.5 – 1.7) 0.0007
CRP (mg/L)4,5 0.93 (0.76 – 1.11) 1.03 (0.85 – 1.23) 0.45
1
Data are given as means (95% confidence interval).
2
P values for differences between adolescent girls and premenopausal women using t test and analysis of covariance (for body mass index and
race/ethnicity adjusted values). Log-transformed values were used for CRP calculation.
311 participants had missing values.
41 participant had missing value.
5Geometric mean and 95% confidence interval for geometric mean.
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